Literature DB >> 15074837

Methamphetamine-induced conditioned place preference is facilitated by estradiol pretreatment in female mice.

H H Chen1, Y K Yang, T L Yeh, C F G Cherng, H C Hsu, S Y Hsiao, L Yu.   

Abstract

Ovarian hormones were well documented to modulate the dopamine release in the central dopaminergic systems. The dopamine-releasing effects in the nucleus accumbens, a major target of the mesolimbicortical dopaminergic system, were closely associated with the reinforcing effects of two psychomotor stimulants, cocaine and methamphetamine. This study aimed to examine the sex differences in the cocaine- and methamphetamine-reinforcing behavior, conditioned place preference. In addition, the modulating effects of estradiol and progesterone on methamphetamine-induced conditioned place preference were investigated in both sexes of adult gonadectomized mice. There was no sex difference in the sensitivity to the cocaine (5 mg/kg)-induced conditioned place preference. However, female mice exhibited a more potent methamphetamine (1 mg/kg)-induced conditioned place preference than did male mice. Moreover, pretreatment with estradiol for two consecutive days before the beginning of the conditioning and throughout the four daily conditionings (0.47 microg/day for totally six days) effectively facilitated methamphetamine-induced conditioned place preference in gonadectomized female mice, but not in gonadectomized male mice. Progesterone, under a similar treatment regimen (0.47 microg/day for six consecutive days), did not alter the methamphetamine-induced conditioned place preference in either sex of gonadectomized mice. Taken together, we conclude that the facilitating effects of estradiol on methamphetamine-induced conditioned place preference could be sex-dependent with an eminent sensitivity associated with the adult female mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15074837

Source DB:  PubMed          Journal:  Chin J Physiol        ISSN: 0304-4920            Impact factor:   1.764


  15 in total

Review 1.  Neural mechanisms of reproduction in females as a predisposing factor for drug addiction.

Authors:  Valerie L Hedges; Nancy A Staffend; Robert L Meisel
Journal:  Front Neuroendocrinol       Date:  2010-02-19       Impact factor: 8.606

Review 2.  Estradiol: a key biological substrate mediating the response to cocaine in female rats.

Authors:  Annabell C Segarra; José L Agosto-Rivera; Marcelo Febo; Natasha Lugo-Escobar; Raissa Menéndez-Delmestre; Anabel Puig-Ramos; Yvonne M Torres-Diaz
Journal:  Horm Behav       Date:  2009-12-21       Impact factor: 3.587

Review 3.  Sex differences in drug addiction and response to exercise intervention: From human to animal studies.

Authors:  Yuehui Zhou; Min Zhao; Chenglin Zhou; Rena Li
Journal:  Front Neuroendocrinol       Date:  2015-07-13       Impact factor: 8.606

4.  Interaction of stress and stimulants in female rats: Role of chronic stress on later reactivity to methamphetamine.

Authors:  Eden M Anderson; Lisa M McFadden; Leslie Matuszewich
Journal:  Behav Brain Res       Date:  2019-08-23       Impact factor: 3.332

5.  Ultra-low-dose naltrexone suppresses rewarding effects of opiates and aversive effects of opiate withdrawal in rats.

Authors:  Mary C Olmstead; Lindsay H Burns
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

6.  Estradiol enhances ethanol reward in female mice through activation of ERα and ERβ.

Authors:  Elisa R Hilderbrand; Amy W Lasek
Journal:  Horm Behav       Date:  2018-02-09       Impact factor: 3.587

7.  Netrin-1 receptor-deficient mice show age-specific impairment in drug-induced locomotor hyperactivity but still self-administer methamphetamine.

Authors:  Jee Hyun Kim; Doron Lavan; Nicola Chen; Cecilia Flores; Helen Cooper; Andrew J Lawrence
Journal:  Psychopharmacology (Berl)       Date:  2013-07-03       Impact factor: 4.530

8.  Estradiol replacement enhances cocaine-stimulated locomotion in female C57BL/6 mice through estrogen receptor alpha.

Authors:  Amanda E D Van Swearingen; Cristina L Sanchez; Suzanne M Frisbee; Antonia Williams; Q David Walker; Kenneth S Korach; Cynthia M Kuhn
Journal:  Neuropharmacology       Date:  2013-04-19       Impact factor: 5.250

Review 9.  Sexual Differentiation and Substance Use: A Mini-Review.

Authors:  Samuel J Harp; Mariangela Martini; Wendy J Lynch; Emilie F Rissman
Journal:  Endocrinology       Date:  2020-09-01       Impact factor: 4.736

Review 10.  Ovarian hormones and drug abuse.

Authors:  Megan M Moran-Santa Maria; Julianne Flanagan; Kathleen Brady
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.